Newron Pharmaceuticals Participates in Healthcare Conferences
Newron Pharmaceuticals participated in conferences hosted by Guggenheim and Jefferies.
Related stories
Nextensa Sells Luxembourg Office Building for EUR43.5 Million
Nextensa announced the sale of a Luxembourg office building to Centre Hospitalier de Luxembourg for EUR43.5 million.
L impact | EQUITY | Oct 29, 2026, 02:40 PM UTC
Shenzhen Longsys Electronics Reports Quarterly Revenue of RMB 14.63 Billion
M impact | EQUITY | Oct 29, 2026, 02:39 PM UTC
SUMMI Group Delays FY26 Annual Results Publication
SUMMI Group’s FY26 annual results publication is delayed due to audit procedures.
M impact | EQUITY | Oct 29, 2026, 02:39 PM UTC
Shenzhen Longsys Electronics Reports Quarterly Net Profit of RMB 3.74 Billion
M impact | EQUITY | Oct 29, 2026, 02:39 PM UTC
Insperity Shares Fall More Than 13% After Q3 Results and Updated Guidance
Insperity shares fell more than 13% after the company reported third-quarter results and updated its 2026 adjusted earnings guidance.
M impact | EQUITY | Oct 29, 2026, 02:38 PM UTC
Novavax Earns $125 Million Milestone Payment From Sanofi Vaccine Trial
Novavax earned a $125 million milestone payment from Sanofi's Phase 3 vaccine trial in Europe.
M impact | EQUITY | Oct 29, 2026, 02:38 PM UTC